Market Currents
Henry Schein (HSIC -7.4%) beat Q3 estimates, but earnings climbed less-than-expected as the...
-
Tuesday, November 1, 2011, 12:28 PM ETHenry Schein (HSIC -7.4%) beat Q3 estimates, but earnings climbed less-than-expected as the vaccine maker suffered from lower sales of its flu shots and margin pressure due to higher costs. The company also issues cautious guidance for FY12, citing foreign currency concerns.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
